Makale detayı · 2017 · article
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec
ISSN2152-2650
YÖKSİS
OpenAlex
Üst %10
Yıl2017
Atıf25OpenAlex
Atıf19Semantic Scholar
Yüzdelik%90,5
FWCI2,541,00 = dünya ortalaması
Scopus (SJR)Q2
WoS (JCR)Q3
Veri kaynağı ayrımı
- YÖKSİSYÖKSİS makale kaydı
- YÖKSİS dergi adıClinical Lymphoma Myeloma and Leukemia
- Katalog eşleşmesi (ISSN)Clinical Lymphoma, Myeloma and Leukemia
- OpenAlexOpenAlex zenginleştirmesi (özet, atıf, konular)
- Semantic Scholaratıf sayısı (OpenAlex ile birleştirilmez)
Özet
Özet henüz derlenmedi; DergiPark / OpenAlex kuyruğu işlenince burada görünecek.
Konular
Atıflar
OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.
25atıfOpenAlex · cited_by_count (önbellek / veritabanı)
Yerel katalogda bu makaleye atıf yapan 12 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).
- 2022 Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similaritiesAtıf 41 · OpenAlex
- 2022 Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similaritiesAtıf 41 · OpenAlex
- 2021 Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costsAtıf 35 · OpenAlex
- 2018 Generic formulations of imatinib for treatment of Philadelphia chromosome-positive leukemia in pediatric patientsAtıf 16 · OpenAlex
- 2020 Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid LeukemiaAtıf 11 · OpenAlex
- 2020 Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid LeukemiaAtıf 11 · OpenAlex
- 2024 A safety review of tyrosine kinase inhibitors for chronic myeloid leukemiaAtıf 6 · OpenAlex
- 2024 A safety review of tyrosine kinase inhibitors for chronic myeloid leukemiaAtıf 6 · OpenAlex
- 2019 The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019;104(7):e293)Atıf 4 · OpenAlex
- 2019 The tolerability issue of generic imatinib in patients with chronic myeloid leukemia (Comment on Adi J. Klil-Drori et al., Haematologica 2019104(7):e293).Atıf 4 · OpenAlex